Evidence map›Paper›PMID 41178894›Full record

ArticleWorld journal of gastrointestinal surgery2025

ANXA13 expression patterns in hepatocellular carcinoma and impact on tumor behavior.

Shu-Kuan Yang, Xue-Kai Zhao, Yang-Yang Cui, De-Zheng Liu, Zi-Jian Zhao, Lei Zhou, Lin Wang, Fan Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastrointestinal surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shu-Kuan YangDepartment of Biliary-Pancreatic Surgery, The Affiliated Hospital of Binzhou Medical University, Binzhou 256603, Shandong Province, China.
Xue-Kai ZhaoDepartment of General Surgery, Binzhou People's Hospital, Binzhou 256600, Shandong Province, China.
Yang-Yang CuiDepartment of Biliary-Pancreatic Surgery, The Affiliated Hospital of Binzhou Medical University, Binzhou 256603, Shandong Province, China.
De-Zheng LiuDepartment of Biliary-Pancreatic Surgery, The Affiliated Hospital of Binzhou Medical University, Binzhou 256603, Shandong Province, China.
Zi-Jian ZhaoDepartment of Biliary-Pancreatic Surgery, The Affiliated Hospital of Binzhou Medical University, Binzhou 256603, Shandong Province, China.
Lei ZhouDepartment of Biliary-Pancreatic Surgery, The Affiliated Hospital of Binzhou Medical University, Binzhou 256603, Shandong Province, China. dr_zhlei@163.com.
Lin WangDepartment of Ophthalmology, The Affiliated Hospital of Binzhou Medical University, Binzhou 256603, Shandong Province, China.
Fan ZhangDepartment of Biliary-Pancreatic Surgery, The Affiliated Hospital of Binzhou Medical University, Binzhou 256603, Shandong Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEmerging evidence has demonstrated that

aimTo examine the expression of

methodsQuantitative real-time PCR and western blotting were performed to detect the

results

conclusionANXA13 was upregulated in HCC. Its overexpression promotes tumor progression and is associated with advanced clinicopathological features, suggesting ANXA13 as a potential biomarker and therapeutic target for HCC.

Indexed as

ANXA13BiomarkerHepatocellular carcinomaPost-transcriptional regulationTumor progression

Identifiers

PMID41178894
PMCPMC12576647

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.